EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prifti, E.
Right arrow Articles by Sani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prifti, E.
Right arrow Articles by Sani, G.

Eur J Cardiothorac Surg 1998;14:643-644
© 1998 Elsevier Science NL


Letter to the Editor

Coronary revascularization after liver transplantation

E. Prifti, M. Maccherini, G. Capannini, G. Sani

Istituto di Chirurgia Toracica, Cardiovascolare e Tecnologie Biomediche, Universita degli Studi di Siena, c/o Ospedale Le Scotte, Viale Bracci 1, Siena 53100, Italy

Received 16 March 1998; received in revised form 31 August 1998; accepted 30 September 1998.

Corresponding author. Tel: +39-577-585-731; fax: +39-577-586-168; e-mail: htx@biolab.med.unisi.it

The first 20% of the full text of this article appears below.

Liver transplantation as an effective procedure in end-stage liver disease has created an increasing pool of patients developing systemic atherosclerosis and coronary artery disease (CAD).

A 55-year-old man with a 20-year history of type II diabetes treated with insulin and chronic bronchitis, reversible strokes, 6-year history of hypertension, esophageal varices, porto-caval anastomosis for an end-stage liver disease secondary to hepatitis B, underwent orthotopic liver transplantation in January 1994; 6 months later, the choledoc ductus was dilated and stented. Triple immunosuppressive therapy (cyclosporine, azathioprine, and prednisone) occurred between 1994 and 1996, while in January 1997 a monotherapy with Cya (3 mg/kg per day of Neoral) was started. At that time the patient presented unstable angina followed by acute . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.